Brief: Evoke Pharma Regains Compliance With Nasdaq Listing Requirements
08/06/2022 14:19
June 8 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA REGAINS COMPLIANCE WITH NASDAQ LISTING
REQUIREMENTS
AND PROVIDES FINANCIAL UPDATE
* EVOKE PHARMA INC - CASH RAISED FROM "AT-THE-MARKET"
PROGRAM
EXTENDS CASH RUNWAY INTO Q2 OF 2023
Source text for Eikon: ID:nGNX33Hc6y
Further company coverage: EVOK.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary